News
Компания «ДНК-Технологии» является единственным отечественным производителем оборудования и материалов для полного технологического цикла для выполнения молекулярно - генетических исследований методом ПЦР в реальном времени.
main new
News
-
TELEGRAM CHANNEL OF DNA-TECHNOLOGY COMPANY
Subscribe to our channels.
Stay updated on company news, latest developments, and events. -
DNA TECHNOLOGY AT WHX LABS KUALA LUMPUR 2025
From July 16 to 18, we participated in WHX Labs, the leading medical laboratory technology exhibition in Southeast Asia.
The event brought together over 350 exhibitors and 10,000 professionals, serving as a key platform for knowledge exchange, innovation presentations, and partnership agreements in the field of laboratory diagnostics.
At our booth, we showcased the company’s latest developments:
- DTstream Robotic Stations – Automation for PCR laboratories with ultra-precise dosing.
- DTprime II Detection Amplifiers – Enhanced sensitivity and faster analysis.
- PCR and NGS reagent kits.We placed special emphasis on reproductive health solutions. Our technologies play a key role in IVF, ensuring:
- Accurate diagnosis of latent infections (BacScreen OM + BacResist GLA).
- Microbiome screening before pregnancy (Femoflor®/Androflor®).Reduced risk of complications:
- AneuScreen – Non-invasive prenatal DNA test (NIPT) for detecting fetal aneuploidies from maternal blood.
- AneuPGT – Preimplantation genetic testing (PGT) for identifying chromosomal abnormalities in IVF embryos.On July 17, as part of the "Molecular Diagnostics and Genetics" conference supported by our company, a presentation by Dr. Med. Sci., Prof. Ekaterina Voroshilina titled "New Approaches to Overcoming Reproductive Challenges in Couples" was delivered. The talk sparked active engagement among reproductive medicine and genetics specialists.
Participation in WHX Labs Kuala Lumpur 2025 allowed us to:
- Strengthen our position in the Asian market.
- Establish new business connections.
- Demonstrate cutting-edge laboratory diagnostics solutions.We thank our visitors and partners for their interest.
We are in Telegram»
-
DNA-TECHNOLOGY PRESENTED COMPANY SOLUTIONS DURING THE BUSINESS MISSION IN MEXICO
DNA-Technology took part in the business mission of Russian companies to Mexico (August 19 to 21, 2025), organized by the Moscow Export Center (MEC). The mission was aligned with ExpoMed in Mexico City, one of the largest international medical technology exhibitions in Latin America.
As part of the delegation, Russian companies negotiated and business meetings with both government and private medical organizations in Mexico, and also participated in industry-specific panel discussions.
Representing DNA-Technology, Head of the International Sales Department Sergey Labutin:
- presented the company’s products and molecular diagnostics technologies at the ExpoMed venue;
- delivered presentations on innovative solutions in laboratory diagnostics;
- conducted negotiations on potential cooperation with representatives of Mexican governmental and private institutions at key venues
the Embassy of the Russian Federation, CONCAMIN / CONOSINTRA, and the Cámara Nacional de Comercio de la Ciudad de México (National Chamber of Commerce of Mexico City);
- gave interviews to local media, emphasizing the importance of Russian-Mexican cooperation in medicine and biotechnology.
Mexican colleagues highly appreciated the company’s products and technological solutions, showing particular interest in:
- automated diagnostic solutions in both human and veterinary medicine;
- innovative equipment systems and PCR-based diagnostic kits.
It was especially noted that Russian solutions are distinguished by their high quality and price accessibility, making them highly competitive in the Latin American market.
DNA-Technology considers the Latin American market as a strategically important direction for the export of high-tech products. Participation in the business mission marked a significant step in expanding the company’s international presence and laid the foundation for future joint projects with Mexican partners.
At the same time, much work still lies ahead to develop and strengthen these business relations. Nevertheless, we are confident that this cooperation has significant potential and opens up broad prospects for both sides.
-
OUTCOMES OF WHX CAPE TOWN 2025: DNA-TECHNOLOGY STRENGTHENS ITS PRESENCE IN THE AFRICAN LABORATORY DIAGNOSTICS MARKET
From September 2nd to 4th, 2025, the WHX Cape Town 2025, the largest African exhibition of medical and laboratory technologies, was successfully held in Cape Town, South Africa. DNA-Technology acted as the gold sponsor of this key industry event, and our booth enjoyed incredible popularity throughout all the exhibition days, attracting a many of visitors.
The event proved to be an exceptionally productive platform, allowing us not only to present our innovations but also to establish new business connections and partnerships with key market players.
Among the numerous visitors, our key developments drew particular attention:
- DTstream Robotic Stations — a revolutionary solution for laboratory process automation that generated keen interest among attendees.
- The latest DTprime II Amplifiers — next-generation equipment that impressed specialists with its unique detection accuracy.
- FEMOFLOR ®/ANDROFLOR® diagnostic systems — the recognized gold standard in urogenital microbiome research.The guests paid especially close attention to the presentation on the women's health solution. Specialists showed high interest in the capabilities of:
BacScreen OM for detecting opportunistic microflora.
The new FEMOFLOR®II for a comprehensive assessment of the microbiocenosis state.
These solutions were also reflected in the scientific report "Assessing urinary microbiota in chronic cystitis by PCR method," presented by our experts at the Labs Conference. The report provided a detailed analysis of a new, more accurate approach to diagnosing chronic cystitis using comprehensive PCR analysis, which allows for assessing the state of the entire urinary microbiota rather than searching for a single pathogen. The presentation of clinical cases and new laboratory diagnostics capabilities sparked an active discussion among specialists.
We thank everyone who visited our booth.
The success at WHX Cape Town 2025 and the interest in our products inspire us to further develop and strengthen partnerships in the dynamically growing African market.Check out the video to see how the event went.